Our findings revealed that the levels of PAK1 and HDAC10 were elevated compared to those observed in individuals without breast cancer across various stages of the disease, while the expression level of HDAC6 displayed no significant change (Fig. 1A to C). Here, PAK1 is linked to breast cancer.